Breast CancerNCT06260332
Physical Activity Intervention for the Improvement of Pain in Young, Hispanic Breast Cancer Survivors
A study testing Supportive Care (Fitbit) in people with Breast Cancer, run by New Mexico Cancer Research Alliance at 1 site in United States.
Trial summary
This clinical trial tests whether increased activity throughout the day can improve the chronic pain and associated symptoms that breast cancer survivors may experience after surgery. Staying active is a key factor of one's physical, mental, and social health and well-being. Read more about this study
- Who is it for?
- Ages 18 to 60 years, women only
- Conditions the study is for
- Breast Cancer
- What is being tested?
- Supportive Care (Fitbit)
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 25 participants
- Where
- 1 siteUnited States
- Study dates
- 20 Oct 2023to 31 Dec 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- Women only
- No healthy volunteers
- Adult
Who may be able to join
- Women who have completed surgery for invasive breast cancer >= 6 months prior to enrollment
- Any breast surgery (lumpectomy or mastectomy)
- Baseline low to moderate activity level (exercise less than 120 minutes a week)
- PBSPS defined as pain in the area of breast surgery of at least moderate intensity (>= 4 on a scale of 1-10), located in the ipsilateral beast/chest wall, axilla or arm, lasting at least 6 months, and occurring at least 50% of the time
- Self-identified as Hispanic/Latinx
- Age, >= 18 and =< 60 years
- Endocrine therapy and ovarian suppression is allowed
Who cannot join
- Metastatic or locally recurrent disease with no option for curative intent treatment
- Meeting or exceeding physical activity guidelines (> 150 minutes per week of moderate-intensity exercise)
- Unable to speak, read, and understand English or Spanish
- Severe impairments (in seeing or hearing) or pre-existing medical limitations for engaging in daily physical activity. This is defined as the ability to walk 3 blocks without stopping to rest and without using an assistive device
- Unwilling to use a study provided smartphone (if do not already own one) and wear activity trackers/monitors
- Adults not able to consent are excluded from participation
Show all 9Show fewer
- Based on the age criteria (18 years and older), individuals who are not yet adults (infants, children, teenagers) may not participate in this study due to the same age criteria above
- Pregnant women
- Prisoners may not participate in this study as this is a study of free-living individuals
Trial locations and contacts
1 site in 1 country.
United States1 site
University of New Mexico Comprehensive Cancer Center
Albuquerque, New Mexico, 87106
About this study
Official title: Move Toward Recovery: A Physical Activity Intervention to Reduce Persistent Pain Following Breast Surgery for Cancer in Young, Hispanic Women
This clinical trial tests whether increased activity throughout the day can improve the chronic pain and associated symptoms that breast cancer survivors may experience after surgery. Staying active is a key factor of one's physical, mental, and social health and well-being. Moving more could also reduce pain and associated stress, anxiety, or depression. Using a fitness tracker may help patients to move around more, whether or not they choose to exercise. Information gathered from this study may help researchers learn how the use of a Fitbit tracker with health coaching may improve physical activity and reduce pain in young, Hispanic breast cancer survivors.
Read the detailed description
PRIMARY OBJECTIVE:
- To assess the feasibility of a physical activity intervention in young, Hispanic women with chronic post-operative pain after breast surgery for invasive breast cancer, termed post breast surgery pain syndrome (PBSPS) for this study.
SECONDARY OBJECTIVES:
- To assess the preliminary efficacy of a physical activity intervention in decreasing pain in young, Hispanic women with PBSPS.
II. To assess the preliminary efficacy of the physical activity intervention in increasing physical activity and improving health-related quality of life (hrQOL).
OUTLINE:
Patients wear a Fitbit and use the Fitbit application to monitor their physical activity daily in weeks 2-12 with the goal of increasing their number of steps per day and their number of active hours per day. Starting at week 2, patients also receive educational materials and attend 6 calls over 20-60 minutes each with their health coach in weeks 2, 3, 5, 7, 9, and 11.
- Conditions
- Breast Cancer
- Being tested
- Supportive Care (Fitbit)
- Medical subject headings
- Breast Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Supportive Care (Fitbit)Behavioural
Also called Medical Device Usage and Evaluation, Internet-Based Intervention, Educational Activity, Counseling
Wear Fitbit, Use Fitbit application, Receive educational materials, attend coaching calls, Ancillary studies
| Study group | Role | What they receive |
|---|---|---|
| Supportive Care (Fitbit) | Experimental | Patients wear a Fitbit and use the Fitbit application to monitor their physical activity daily in weeks 2-12 with the goal of increasing their number of steps per day and their number of active hours per day. Starting at week 2, patients also receive educational materials and attend 6 calls over 20-60 minutes each with their health coach in weeks 2, 3, 5, 7, 9, and 11. Receives: Behavioral: Supportive Care (Fitbit) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Recruitment rate (Feasibility)
This study will be considered feasible with the recruitment of 25 breast cancer patients.
Measured: Up to 1 year
Retention rate (Feasibility)
This study will be considered feasible if 80% of patients complete all pre and post assessments.
Measured: Up to 12 weeks
Adherence rate (Feasibility)
This study will be considered feasible if participants complete at least 4 of 5 health coaching sessions (80%).
Measured: Up to 12 weeks
Incidence of adverse events
Safety will be tracked by the study team.
Measured: Up to 12 weeks
Secondary outcomes (3)
Change in chronic post-surgical pain
Reducing chronic post-surgical pain will be measured using the Defense and Veterans Pain Rating Scale. Will also be assessed by Bodily Threat Monitoring Scale and pain self-efficacy questionnaire. Will summarize change scores with means and standard deviations, or medians and interquartile ranges, and obtain 95% confidence intervals. Will perform one-sided paired t-tests, or Wilcoxon signed rank tests.
Measured: At 13 weeks
Change in physical activity
Increasing physical activity will be measured using accelerometry data using the activePAL activity monitor. Will summarize change scores with means and standard deviations, or medians and interquartile ranges, and obtain 95% confidence intervals. Will perform one-sided paired t-tests, or Wilcoxon signed rank tests.
Measured: At 13 weeks
Change in health-related quality of life (hrQOL)
Improvement in hrQOL will be measured using Patient-Reported Outcomes Measurement Information System surveys. Will summarize change scores with means and standard deviations, or medians and interquartile ranges, and obtain 95% confidence intervals. Will perform one-sided paired t-tests, or Wilcoxon signed rank tests.
Measured: At 13 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Feb 2024
- Study start20 Oct 2023
- Primary completion27 Aug 2024
- Study completion31 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Breast CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 25 participants (estimated)
Sponsor and investigators
- Lead sponsor
- New Mexico Cancer Research Alliance
- Sponsor type
- University, hospital or other
- Collaborators
- University of New Mexico
- Responsible party
- Sponsor
- Investigators
- Jacklyn M Nemunaitis, MD, Principal investigator, New Mexico Cancer Research AllianceCindy K Blair, Ph.D., Principal investigator, New Mexico Cancer Research Alliance
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06260332
- Sponsor's protocol ID
- INST UNM 2302
- Other IDs
- 23-293
- Status last verified
- Oct 2025
- First submitted
- 23 Jan 2024
- Last updated
- 23 Oct 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Rosenberg S, Boyce T, Walters ST, Barriga L, Torres J, Pankratz VS, Tawfik B, Prabhakaran S, Fine S, Buro AW, Brown Glaberman U, Blair C, Nemunaitis J. Move Toward Recovery: A Feasibility Study for a Physical Activity Intervention to Reduce Post-Surgical Pain in Young Hispanic Breast Cancer Patients. Int J Environ Res Public Health. 2026 Jul 31;23(8):1003. doi: 10.3390/ijerph23081003.
PubMed 42652318
Study at a glance
From the registry record, last updated by the sponsor on 23 Oct 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Move Toward Recovery: A Physical Activity Intervention to Reduce Persistent Pain Following Breast Surgery for Cancer in Young, Hispanic Women
- ClinicalTrials.gov ID
- NCT06260332
- Acronym / sponsor ID
- INST UNM 2302
- Conditions
- Breast Cancer
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 25 participants (estimated)
- Lead sponsor
- New Mexico Cancer Research AllianceUniversity, hospital or other
- Collaborators
- University of New Mexico
- Study start
- 20 Oct 2023 (actual)
- Primary completion
- 27 Aug 2024 (actual)
- Study completion
- 31 Dec 2026 (estimated)
- First posted
- 15 Feb 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This clinical trial tests whether increased activity throughout the day can improve the chronic pain and associated symptoms that breast cancer survivors may experience after surgery. Staying active is a key factor of one's physical, mental, and social health and well-being. Moving more could also reduce pain and associated stress, anxiety, or depression. Using a fitness tracker may help patients to move around more, whether or not they choose to exercise. Information gathered from this study may help researchers learn how the use of a Fitbit tracker with health coaching may improve physical activity and reduce pain in young, Hispanic breast cancer survivors.
Detailed description
PRIMARY OBJECTIVE:
- To assess the feasibility of a physical activity intervention in young, Hispanic women with chronic post-operative pain after breast surgery for invasive breast cancer, termed post breast surgery pain syndrome (PBSPS) for this study.
SECONDARY OBJECTIVES:
- To assess the preliminary efficacy of a physical activity intervention in decreasing pain in young, Hispanic women with PBSPS.
II. To assess the preliminary efficacy of the physical activity intervention in increasing physical activity and improving health-related quality of life (hrQOL).
OUTLINE:
Patients wear a Fitbit and use the Fitbit application to monitor their physical activity daily in weeks 2-12 with the goal of increasing their number of steps per day and their number of active hours per day. Starting at week 2, patients also receive educational materials and attend 6 calls over 20-60 minutes each with their health coach in weeks 2, 3, 5, 7, 9, and 11.
Study design
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Supportive Care (Fitbit) | Experimental | Behavioral: Supportive Care (Fitbit)Patients wear a Fitbit and use the Fitbit application to monitor their physical activity daily in weeks 2-12 with the goal of increasing their number of steps per day and their number of active hours per day. Starting at week 2, patients also receive educational materials and attend 6 calls over 20-60 minutes each with their health coach in weeks 2, 3, 5, 7, 9, and 11. |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (7 listed)
- Women who have completed surgery for invasive breast cancer >= 6 months prior to enrollment
- Any breast surgery (lumpectomy or mastectomy)
- Baseline low to moderate activity level (exercise less than 120 minutes a week)
- PBSPS defined as pain in the area of breast surgery of at least moderate intensity (>= 4 on a scale of 1-10), located in the ipsilateral beast/chest wall, axilla or arm, lasting at least 6 months, and occurring at least 50% of the time
- Self-identified as Hispanic/Latinx
Key exclusion criteria (9 listed)
- Metastatic or locally recurrent disease with no option for curative intent treatment
- Meeting or exceeding physical activity guidelines (> 150 minutes per week of moderate-intensity exercise)
- Unable to speak, read, and understand English or Spanish
- Severe impairments (in seeing or hearing) or pre-existing medical limitations for engaging in daily physical activity. This is defined as the ability to walk 3 blocks without stopping to rest and without using an assistive device
- Unwilling to use a study provided smartphone (if do not already own one) and wear activity trackers/monitors
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Supportive Care (Fitbit)Also: Medical Device Usage and Evaluation, Internet-Based Intervention, Educational Activity, CounselingWear Fitbit, Use Fitbit application, Receive educational materials, attend coaching calls, Ancillary studies | Behavioural | Supportive Care (Fitbit) |
Primary outcome
Recruitment rate (Feasibility)
Time frame: Up to 1 year
This study will be considered feasible with the recruitment of 25 breast cancer patients.
Retention rate (Feasibility)
Time frame: Up to 12 weeks
This study will be considered feasible if 80% of patients complete all pre and post assessments.
Adherence rate (Feasibility)
Time frame: Up to 12 weeks
This study will be considered feasible if participants complete at least 4 of 5 health coaching sessions (80%).
Incidence of adverse events
Time frame: Up to 12 weeks
Safety will be tracked by the study team.
3 secondary outcomes
Change in chronic post-surgical pain
Time frame: At 13 weeks
Change in physical activity
Time frame: At 13 weeks
Change in health-related quality of life (hrQOL)
Time frame: At 13 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Oct 2025.
- Derived from this study: PubMed 42652318Rosenberg S, Boyce T, Walters ST, Barriga L, Torres J, Pankratz VS, Tawfik B, Prabhakaran S, Fine S, Buro AW, Brown Glaberman U, Blair C, Nemunaitis J. Move Toward Recovery: A Feasibility Study for a Physical Activity Intervention to Reduce Post-Surgical Pain in Young Hispanic Breast Cancer Patients. Int J Environ Res Public Health. 2026 Jul 31;23(8):1003. doi: 10.3390/ijerph23081003.
- NIH. (n.d.). Cancer of the breast (female) - cancer stat facts. SEER. Retrieved January 22, 2023Link provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for Breast Cancer
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
RecruitingPhase 2
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
Invasive Mammary Carcinoma, Metastatic Breast Cancer
Not yet recruitingObservational study
Comparison of Reliability, Time Cost, and Participant Comfort of Lymphedema Assessments in Upper Extremity
Lymphedema, Upper Extremity Lymphedema
RecruitingPhase 3
A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01)
TNBC - Triple-Negative Breast Cancer
RecruitingPhase 3
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jacklyn M Nemunaitis, MD principal investigator
New Mexico Cancer Research Alliance
Cindy K Blair, Ph.D. principal investigator
New Mexico Cancer Research Alliance
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Supportive Care (Fitbit) in people with Breast Cancer, run by New Mexico Cancer Research Alliance at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 23 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Recruitment rate (Feasibility) (time frame: Up to 1 year). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06260332, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Oct 2025.